Extrafine inhaled triple therapy vs dual bronchodilators in patients with chronic obstructive pulmonary disease

被引：0
|
作者：
不详
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2018年 / 79卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [31] The Future of Triple Therapy in chronic obstructive pulmonary disease
    Alcazar-Navarrete, Bernardino
    Castellano Minan, Francisca
    Romero Palacios, Pedro J.
    ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (02): : 63 - 64
  • [32] Triple Therapy in Chronic Obstructive Pulmonary Disease Reply
    Lipson, David A.
    Barnacle, Helen
    Birk, Ruby
    Brealey, Noushin
    Locantore, Nicholas
    Lomas, David A.
    Ludwig-Sengpiel, Andrea
    Mohindra, Rajat
    Tabberer, Maggie
    Zhu, Chang-Qing
    Pascoe, Steven J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (08) : 1083 - 1084
  • [33] Optimal treatment of chronic obstructive pulmonary disease: The search for the magic combination of inhaled bronchodilators and corticosteroids
    Criner, Gerard J.
    ANNALS OF INTERNAL MEDICINE, 2007, 146 (08) : 606 - 608
  • [34] Cardiovascular Safety of Inhaled Long-Acting Bronchodilators in Individuals With Chronic Obstructive Pulmonary Disease
    Gershon, Andrea
    Croxford, Ruth
    Calzavara, Andrew
    To, Teresa
    Stanbrook, Matthew B.
    Upshur, Ross
    Stukel, Therese A.
    JAMA INTERNAL MEDICINE, 2013, 173 (13) : 1175 - 1184
  • [35] Are inhaled corticosteroids systemic therapy for chronic obstructive pulmonary disease?
    Calverley, P
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (07) : 721 - 722
  • [36] Triple therapy vs. dual bronchodilator therapy for chronic pulmonary disease: Is it worth the cost?
    Horita, Nobuyuki
    Kaneko, Takeshi
    RESPIRATORY INVESTIGATION, 2015, 53 (04) : 173 - 175
  • [37] COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA
    Schembri, S.
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, A.
    Risebrough, N.
    Thrasis, A.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    RESPIROLOGY, 2020, 25 : 145 - 145
  • [38] COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA
    Schembri, S.
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, K.
    Risebrough, N.
    Thrasis, A.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    RESPIROLOGY, 2021, 26 : 119 - 119
  • [39] CHRONIC KIDNEY DISEASE LEADS TO ADVERSE CARDIOVASCULAR EVENTS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS USING INHALED LONG-ACTING BRONCHODILATORS
    Cheng, Yi-Ching
    Chen, Yen-Fu
    Chen, Chung-Yu
    RESPIROLOGY, 2018, 23 : 122 - 123
  • [40] COST-EFFECTIVENESS OF ROFLUMILAST AS ADD-ON TO TRIPLE INHALED THERAPY VERSUS TRIPLE INHALED THERAPY IN PATIENTS WITH SEVERE AND VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSOCIATED WITH CHRONIC BRONCHITIS IN THE NETHERLANDS
    Miquel-Cases, A.
    Berk, A.
    Nekeman, S.
    Bastiaanse, M.
    Sellink, A. A.
    Ruiz, S.
    VALUE IN HEALTH, 2017, 20 (09) : A645 - A645
12345